Alexander Dimitrief - 02 Mar 2025 Form 4 Insider Report for Sotera Health Co (SHC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
04 Mar 2025, 20:34:18 UTC
Prior SEC filing
19 Aug 2024
Next SEC filing
16 May 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Matthew J. Klaben, Attorney-in-Fact

Key filing fact

Alexander Dimitrief filed Form 4 for Sotera Health Co (SHC) on 04 Mar 2025.

Key facts

  • This page summarizes Alexander Dimitrief's Form 4 filing for Sotera Health Co (SHC).
  • 3 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 04 Mar 2025, 20:34.

Change

  • Previous filing in this sequence was filed on 19 Aug 2024.
  • Current net transaction value: -$102,391.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SHC transaction

Common Stock, $0.01 par value per share ("Common Stock")

Tax liability

Transaction value
$102,391
Shares
-8,211
Change %
-2.9%
Price
$12.47
Shares after
278,672
Date
02 Mar 2025
Ownership
Direct
Footnotes
F1
SHC transaction

Common Stock

Award

Transaction value
$0
Shares
+56,053
Change %
+20%
Price
$0.000000
Shares after
334,725
Date
03 Mar 2025
Ownership
Direct
Footnotes
F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SHC transaction Derivative

Performance RSUs

Award

Transaction value
$0
Shares
+28,026
Change %
Price
$0.000000
Shares after
28,026
Date
03 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
28,026
Exercise price
Footnotes
F4
SHC holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
102,095
Date
02 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
102,095
Exercise price
$14.59
Footnotes
F5, F6
SHC holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
602,387
Date
02 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
602,387
Exercise price
$6.37
Footnotes
F5, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 17,135 Restricted Stock Units ("RSUs"), which represents 33% of the RSU award granted to the Reporting Person on March 4, 2024. This award was granted pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to recieve one share of Common Stock, subject to vesting conditions.

Footnote F2

These securities consist of RSUs that were granted on March 3, 2025, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026.

Footnote F3

These securities consist of 90,323 RSUs and 244,402 shares of Common Stock that have vested.

Footnote F4

These securities consist of a maximum number of additional performance-based RSUs that were granted on March 3, 2025, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each additional RSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related performance conditions. The additional RSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026, subject to performance.

Footnote F5

No transaction is being reported on this line. Reported on a previously filed Form 4.

Footnote F6

These options were granted on March 4, 2024, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest annually in three equal installments commencing March 2, 2025, subject to vesting conditions.

Footnote F7

These options were granted on November 7, 2022, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in two equal installments on each of October 31, 2023 and October 31, 2024, subject to the Reporting Person's continued service through each such date.

SEC remarks

The Power of Attorney for Mr. Dimitrief is filed as an exhibit to the Form 3 filed on November 8, 2022, which is hereby incorporated by reference.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .